Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Paviour Pharmaceuticals is a specialty pharmaceutical company headquartered in New Delhi, India, dedicated to the development and commercialization of high-quality therapeutic solutions. The company maintains a diverse portfolio that spans several critical medical fields, including oncology, nephrology, gastroenterology, and critical care. Paviour is recognized for its branded generic products such as Pavi-Alb (Human Albumin) and Pavi-Tax (Paclitaxel), which cater to both domestic and international markets. With a focus on affordability and clinical efficacy, the firm operates through a robust distribution network to ensure the availability of essential medicines. Paviour continues to expand its reach by entering new therapeutic areas and strengthening its manufacturing and marketing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Paviour.